Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 391

FT516 in Combination With Monoclonal Antibodies in Advanced Solid Tumors

FT516 in Combination With Monoclonal Antibodies in Advanced Solid Tumors
Condition:   Solid Tumor, Adult
Interventions:   Drug: FT516;   Drug: Avelumab;   Drug: Cyclophosphamide;   Drug: Fludarabine;   Drug: IL-2
Sponsor:   Fate Therapeutics
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 17, 2020 / by / in
Comments